A carregar...

2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.

In clinical trials with interferon alpha 2b (IFN-alpha 2b) as maintenance therapy for multiple myeloma, the therapeutic benefit is inconclusive. Although the mechanism(s) by which IFN-alpha 2b prolongs remission in some patients is unknown, 2',5'-oligoadenylate synthetase (2,5-A synthetase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Millar, B. C., Bell, J. B.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1995
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2034066/
https://ncbi.nlm.nih.gov/pubmed/8519671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!